PCN352 Treatment Patterns and Performance Status in Unresectable Advanced or Metastatic (ADV/MET) Gastric Cancer (GC), Gastroesophageal Junction Cancer (GEJC) and Esophageal Adenocarcinoma (EAC) Patients Receiving First LINE (1L) Treatment

Autor: Hall, J., Khela, K., Middleton-Dalby, C., Bertwistle, D., Xiao, H.
Zdroj: In Value in Health December 2020 23 Supplement 2:S485-S485
Databáze: ScienceDirect
Externí odkaz: